Critical parameters for D-cycloserine enhancement of cognitive-behaviorial therapy for obsessive-compulsive disorder.
Rothbaum
Barbara Olasov
BO
D000818:Animals; D015928:Cognitive Behavioral Therapy / Q000379:methods*; D003131:Combined Modality Therapy; D003523:Cycloserine / Q000378:metabolism / Q000493:pharmacokinetics / Q000627:therapeutic use*; D005971:Glutamates / Q000378:metabolism; D006801:Humans; D007171:Implosive Therapy / Q000379:methods; D009771:Obsessive-Compulsive Disorder / Q000188:drug therapy / Q000378:metabolism / Q000628:therapy*; D016194:Receptors, N-Methyl-D-Aspartate / Q000819:agonists / Q000378:metabolism; D013569:Synapses / Q000378:metabolism; D009435:Synaptic Transmission / Q000187:drug effects / Q000502:physiology; D016896:Treatment Outcome
D005971:Glutamates; D016194:Receptors, N-Methyl-D-Aspartate; D003523:Cycloserine